Cartesian Therapeutics In... (RNAC)
undefined
undefined%
At close: undefined
18.68
0.08%
After-hours Dec 13, 2024, 04:00 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14
Revenue 26.00M 110.78M 85.08M 16.60M 6.68M 903.00K 207.00K 8.08M 6.01M 3.04M
Cost of Revenue 1.55M 2.04M - - - - - - - -
Gross Profit 24.45M 108.74M 85.08M 16.60M 6.68M 903.00K 207.00K 8.08M 6.01M 3.04M
Operating Income -86.42M 14.54M -4.60M -56.82M -52.45M -65.02M -63.78M -34.67M -25.30M -15.40M
Interest Income - - - - 834.00K 1.05M 617.00K 234.00K 171.00K 111.00K
Pretax Income -238.71M 34.77M -9.72M -68.88M -55.35M -65.34M -65.32M -36.21M -25.17M -12.88M
Net Income -219.71M 35.38M -25.69M -68.88M -55.35M -65.34M -65.32M -36.21M -25.17M -12.88M
Selling & General & Admin 40.58M 23.86M 20.94M 18.91M 14.36M 17.26M 18.08M 12.25M 7.29M 7.95M
Research & Development 71.84M 72.38M 68.74M 54.51M 42.74M 47.69M 45.16M 29.70M 22.98M 10.49M
Other Expenses - 330.00K 15.00K 89.00K - - - - - -
Operating Expenses 110.87M 96.24M 89.67M 73.42M 57.10M 64.95M 63.24M 41.95M 30.27M 18.44M
Interest Expense 2.83M 3.03M 2.84M 1.56M 1.52M 1.49M 1.21M 1.25M 948.00K 552.00K
Selling & Marketing Expenses - - - - - - - - - -
Cost & Expenses 112.42M 96.24M 89.67M 73.42M 59.13M 65.92M 63.99M 42.75M 31.32M 18.44M
Income Tax -19.00M -609.00K 15.97M 1.65M 1.86M 1.00 - - - -
Shares Outstanding (Basic) 5.17M 4.83M 3.81M 3.37M 1.52M 746.31K 680.83K 349.80K 621.65K 428.95K
Shares Outstanding (Diluted) 5.17M 4.86M 3.81M 3.37M 1.52M 746.31K 680.83K 349.80K 621.65K 428.95K
EPS (Basic) -42.49 7.33 -6.74 -20.42 -36.46 -87.55 -95.94 -103.52 -40.5 -38.17
EPS (Diluted) -42.49 2.98 -6.74 -20.42 -36.46 -87.55 -95.94 -103.52 -40.5 -38.17
EBITDA -235.06M 39.84M -5.16M -65.59M -51.80M -62.87M -63.37M -34.16M -23.18M -11.46M
Depreciation & Amortization 843.00K 2.04M 1.72M 1.73M 2.03M 975.00K 750.00K 802.00K 1.04M 864.00K